Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
934.5000 8.30 (0.90%)
NSE Jul 02, 2026 15:31 PM
Volume: 404.4K
 

logo
Natco Pharma Ltd.
16 Nov 2015
934.50
0.90%
Reliance Securities
3. gSovaldi contributed Rs630mn in 2Q (Rs230mn from B2B business) with operating margins at 28-30%. We believe Sovaldi is an interesting opportunity for the Indian market and Natco's first mover advantage will give it a significant...
Natco Pharma Ltd. has an average target of 1029.00 from 2 brokers.
More from Natco Pharma Ltd.
Recommended